FATIGUE POST VIRAL
Clinical trials for FATIGUE POST VIRAL explained in plain language.
Never miss a new study
Get alerted when new FATIGUE POST VIRAL trials appear
Sign up with your email to follow new studies for FATIGUE POST VIRAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood therapy offers hope for long COVID sufferers
Disease control AVAILABLEThis study offers expanded access to an experimental treatment called REGENECYTE, made from human umbilical cord blood, for people with long COVID. Participants must be 18 or older, have a confirmed post-COVID condition, and test negative for active COVID-19. The goal is to see i…
Matched conditions: FATIGUE POST VIRAL
Sponsor: StemCyte, Inc. • Aim: Disease control
Last updated May 17, 2026 01:49 UTC
-
Can a talking therapy beat chronic fatigue? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at whether a type of talking therapy (transdiagnostic cognitive behavioral therapy) can help reduce fatigue in primary care patients. About 190 adults aged 18-67 with severe fatigue lasting at least 3 months will be randomly assigned to either the therapy or usua…
Matched conditions: FATIGUE POST VIRAL
Phase: NA • Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC